The Healthline report on the Macao Polytechnic University analysis of UK Biobank data correctly flags that current 150-minute guidelines offer only modest 8-9% risk reduction, yet it underplays the study's core limitation: this is observational accelerometer data from 17,243 mostly white, middle-aged adults followed for eight years, not an RCT, so causation remains inferential and healthy-user bias cannot be ruled out. A deeper synthesis with the 2023 AHA scientific statement on exercise and the 2022 meta-analysis in Circulation (n=2.1 million) reveals a consistent dose-response curve where 500-plus minutes of moderate-to-vigorous activity yields 25-35% lower CVD events, with diminishing returns only after 750 minutes. The original coverage missed how fitness-stratified targets (340 min for high-fit vs 370 min for low-fit to reach 20% reduction) point to personalized thresholds rather than universal quadrupling. For emotionally resonant decisions, the actionable one-sentence guidance is this: commit to roughly 600 minutes of brisk aerobic movement weekly—four focused 150-minute sessions that leave you able to talk but not sing—to cut major heart events by more than 30%. Conflicts of interest were minimal in the BJSM paper; UK Biobank funding disclosures show no industry ties affecting results.